PPP1CB and Mycoplasma pneumoniae pneumonia: Notably, Mp is resistant to inhibitors of cell wall synthesis as the bacteria lack a peptidoglycan layer; therefore, macrolide antibiotics are the recommended treatment for Mycoplasma pneumonia (Meyer Sauteur et al., 2016).